, Volume 7, Issue 1, pp 15–23 | Cite as

Characterization of a high-affinity receptor for phorbol esters in rat alveolar macrophages

  • Joseph Chang
Original Articles


Macrophages display varied responses to the tumor promoter, TPA. In this study, a high-affinity receptor for phorbol ester is characterized in a viable alveolar macrophage population. The binding assay is performed using tritiated PDBu and specific binding is demonstrated to be temperature-sensitive. At 37°C, the level of bound ligand reaches maximal binding within 2–5 min but rapidly decays to within 30% of the original specific binding. Equilibrium, however, can be established when the assay is carried out at 4°C. The data indicate that at this temperature maximal binding is reached within 2 h and remains constant there-after. Scatchard analysis shows that the receptor has an apparentKd of 21 nM and each macrophage possesses 2×105 binding sites. Active phorbol derivatives such as TPA and PDBu compete with the labeled ligand for the receptor, whereas the inactive phorbol alcohol does not modulate the specific binding. Mezerein, a related diterpene which has been shown to share some of the properties of phorbol esters, also competes for the binding site. The high-affinity receptor is not affected by zymosan or EIgG phagocytosis. Inflammatory mediators such as prostaglandins E2 and F2a and platelet-activating factor do not compete for the receptor.


Prostaglandin Varied Response Inflammatory Mediator Specific Binding Alveolar Macrophage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Blumberg, P. M. 1980. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters,CRC Crit. Rev. Toxicol. 8:153–197.Google Scholar
  2. 2.
    Phaire-Washington, L., E. Wang, andS. C. Silverstein. 1980. Phorbol myristate acetate stimulates pinocytosis and membrane spreading in mouse peritoneal macrophages.J. Cell mol. 86:634–640.Google Scholar
  3. 3.
    Hoidal, J. R., J. E. Repine, G. D. Beall, F. L. Rasp, Jr., andJ. G. White. 1978. The effect of phorbol myristate acetate on the metabolism and ultrastructure of human alveolar macrophages.Am. J. Pathol. 91:469–476.Google Scholar
  4. 4.
    Laskin, D. L., J. D. Laskin, I. B. Weinstein, andR. A. Carchman. 1980. Modulation of phagocytosis by tumor promoters and epidermal growth factor in normal and transformed macrophages.Cancer Res. 40:1028–1035.Google Scholar
  5. 5.
    Laskin, D. L., J. D. Laskin, F. K. Kessler, I. B. Weinstein, andR. A. Carchman. 1981. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.Cancer Res. 41:4523–4528.Google Scholar
  6. 6.
    Laskin, D. L., J. D. Laskin, I. B. Weinstein, andR. A. Carchman. 1981. Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters.Cancer Res. 41:1923–1928.Google Scholar
  7. 7.
    Dahlgren, M. L., P. Davies, andR. J. Bonney. 1980. Phorbol myristate acetate induces the secretion of elastase by populations of resident and elicited mouse peritoneal macrophages.Biochim. Biophys. Acta 630:338–351.Google Scholar
  8. 8.
    Vassalli, J. D., J. Hamilton, andE. Reich. 1977. Macrophage plasminogen activator: Induction by concanavalin A and phorbol myristate acetate.Cell 11:695–705.Google Scholar
  9. 9.
    Chang, J., F. M. Wigley, andD. S. Newcombe. 1980. Neutral proteases activation of peritoneal macrophage prostaglandin synthesis.Proc. Natl. Acad. Sci. U.S.A. 77:4736–4740.Google Scholar
  10. 10.
    Lee, L. S., andI. B. Weinstein. 1978. Uptake of the tumor promoting agent, 12-O-tetradecanoyl-phorbol-13-acetate by HeLa cells.J. Environ. Pathol. Toxicol. 1:627–639.Google Scholar
  11. 11.
    Schimmel, S. D., G. R. Grotendorst, andR. I. Grove. 1980. Binding of phorbol-12-myristate acetate to cultured myoblasts.Cancer Lett. 9:229–236.Google Scholar
  12. 12.
    Driedger, P. E., andP. M. Blumberg. 1980. Specific binding of phorbol ester tumor promoters.Proc. Natl. Acad. Sct. U.S.A. 77:567–571.Google Scholar
  13. 13.
    Dunphy, W. G., K. B. Declos, andP. M. Blumberg. 1980. Characterization of specific binding of [3H]phorbol-12,13-dibutyrate and [3H]phorbol-12-myristate to mouse brain.Cancer Res. 40:3635–3641.Google Scholar
  14. 14.
    Declos, K. B., D. S. Nagle, andP. M. Blumberg. 1980. Specific binding of phorbol ester tumor promoters to mouse skin.Cell 19:1025–1032.Google Scholar
  15. 15.
    Shoyab, M., andG. J. Todaro. 1980. Specific high affinity cell membranes receptors for biologically active phorbol and ingenol esters.Nature 288:451–455.Google Scholar
  16. 16.
    Sando, J. J., M. L. Hilfiker, D. S. Salomon, andJ. J. Farrar. 1981, Specific receptors for phorbol esters in lymphoid cell populations: Role in enhanced production of T-cell growth factor.Proc. Natl. Acad. Sci. U.S.A. 78:1189–1193.Google Scholar
  17. 17.
    Kielian, M., andZ. A. Cohn. 1981. Phorbol myristate acetate stimulates phagosome-lysosome fusion in mouse macrophages.J. Exp. Med. 154:101–111.Google Scholar
  18. 18.
    Bonney, R. J., P. D. Wightman, M. E. Dahlgren, P. Davies, F. A. Kuehl, Jr., andJ. L. Humes. 1980. Effect of RNA and protein synthesis inhibitors on the release of inflammatory mediators by macrophages responding to phorbol myristate acetate.Biochim. Biophys. Acta 633:410–421.Google Scholar
  19. 19.
    Smidt, R., andE. Hecker. 1975. Autoxidation of phorbol esters under normal storage conditions.Cancer Res. 35:1375–1377.Google Scholar
  20. 20.
    Jones, G. 1973. Release of surface receptors from lymphocytes.J. Immunol. 110:1526–1531.Google Scholar
  21. 21.
    Brune, K., H. Kalin, R. Schmidt, andE. Hecker, 1978. Inflammatory, tumor promoting activities of polycyclic aromatic hydrocarbons and diterpene esters in mouse skin as compared with their prostaglandin releasing potency in vitro.Cancer Lett. 4:333–342.Google Scholar

Copyright information

© Plenum Publishing Corporation 1983

Authors and Affiliations

  • Joseph Chang
    • 1
  1. 1.Department of PharmacologyWyeth Laboratories, Inc.Philadelphia

Personalised recommendations